Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin Alpha 1 in Locally Advanced NSCLC
NCT06139419Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2023
- Primary completion
- Jun 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin alpha 1 in non-small cell lung cancer (NSCLC), sponsored by Sun Yat-sen University. Started Jul 2023; status: completed.
02
Drugs
thymosin alpha 1
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT06139419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06139419.